t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemia

28Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Recently, it was shown that t(10;16)(q22;p13) fuses the MORF and CREBBP genes in a case of childhood acute myeloid leukemia (AML) M5a, with a complex karyotype containing other rearrangements. Here, we report a new case with the MORF-CREBBP fusion in an 84-year-old patient diagnosed with AML M5b, in which the t(10;16)(q22;p13) was the only cytogenetic aberration. This supports that this is a recurrent pathogenic translocation in AML. © 2003 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Vizmanos, J. L., Larráyoz, M. J., Lahortiga, I., Floristán, F., Álvarez, C., Odero, M. D., … Calasanz, M. J. (2003). t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemia. Genes Chromosomes and Cancer, 36(4), 402–405. https://doi.org/10.1002/gcc.10174

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free